X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-12 | OMIC | Spaventa Andrew | CEO | S - Sale+OE | $22.55 | -695 | 141,897 | 0% | -$15,669 | |||||
| M | 2024-09-16 | OMIC | Tang Kevin | 10% | P - Purchase | $14.75 | +122,416 | 372,000 | +49% | +$1,806,220 | |||||
| D | 2024-09-15 | OMIC | Spaventa Andrew | CEO | S - Sale+OE | $12.38 | -175 | 140,685 | 0% | -$2,167 | |||||
| M | 2023-11-16 | OMIC | Spaventa Andrew | CEO | P - Purchase | $0.42 | +118,468 | 4,070,972 | +3% | +$49,612 | |||||
2023-11-16 | OMIC | Glezer Eli N. | Chief Scientific Officer | P - Purchase | $0.43 | +200,000 | 4,570,000 | +5% | +$85,640 | ||||||
| M | 2023-08-11 | OMIC | Kamdar Kim P. | Dir | S - Sale | $0.57 | -631,648 | 3,793,985 | -14% | -$361,986 | |||||
2023-05-17 | OMIC | Glezer Eli N. | Chief Scientific Officer | P - Purchase | $0.82 | +170,000 | 4,355,000 | +4% | +$138,924 | ||||||
2022-12-12 | OMIC | Glezer Eli N. | Chief Scientific Officer | P - Purchase | $2.00 | +50,000 | 4,185,000 | +1% | +$100,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |